Compounding Pharmacists:
Welcome to the Pharmacy Compounding Accreditation Board® informational Web Site for pharmacists and compounding pharmacies.
Statement: PCAB Applauds Continued Access to Compounded
Access to 17-hydroxyprogesterone
Washington, D.C. – The Pharmacy Compounding Accreditation Board (PCAB) applauds the FDA’s recent statement regarding continued access to compounded versions of 17-hydroxyprogesterone, for which there is now an FDA approved drug product, Makena®. 17-hydroxyprogesterone is prescribed to reduce the risk of certain preterm births in women who have had at least one prior preterm birth. continue» |
